Cancer Research

Published by: American Association for Cancer Research  

People

  1. Schram
    Schram
  2. Solit
    Solit
  3. Hudis
    Hudis
  4. Modi
    Modi
  5. Aghajanian
    Aghajanian
  6. Berger
    Berger
  7. Drilon
    Drilon
  8. Friedman
    Friedman
  9. Ladanyi
    Ladanyi
  10. Troso-Sandoval
    Troso-Sandoval

Groups

  1. Department of Medicine (55)
  2. Gynecologic Medicine Service (55)
  3. Solid Tumor Oncology Division (55)
  4. GDMT, Medicine (36)
  5. Gynecology Disease Management Team (36)
  6. Human Oncology and Pathogenesis Program (30)
  7. GSK Faculty (27)
  8. Breast Medicine Service (18)
  9. Early Drug Development Service (15)
  10. Epidemiology and Biostatistics (14)
Search Within
  1. "Gynecologic Medicine Service"
Formats
  1. Meeting Abstract (49)
  2. Journal Article (5)
  3. Editorial (1)
Groups
  1. Department of Medicine (55)
  2. Gynecologic Medicine Service (55)
  3. Solid Tumor Oncology Division (55)
  4. GDMT, Medicine (36)
  5. Gynecology Disease Management Team (36)
  6. Human Oncology and Pathogenesis Program (30)

More Groups

People
  1. Alison Schram (13)
  2. Dmitriy Zamarin (13)
  3. David Hyman (12)
  4. Michael Berger (10)
  5. David Solit (9)
  6. Marc Ladanyi (9)

More People

Years
  1. 2022 (16)
  2. 2021 (4)
  3. 2020 (10)
  4. 2019 (11)
  5. 2018 (2)
  6. 2017 (2)

More Years

Publishers
  1. American Association for Cancer Research (55)

Results (55)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Colorectal carcinomas containing hypermethylated MLH1 promoter and wild-type BRAF/KRAS are enriched for targetable kinase fusions
    Journal Article

    Cocco, E.; Benhamida, J.; Middha, S.; Zehir, A.; Mullaney, K.; Shia, J.; Yaeger, R.; Zhang, L.; Wong, D.; Villafania, L.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • A phase Ib study of miransertib (ARQ 092) in combination with anastrozole in patients with PIK3CA or AKT1-mutant ER+ endometrial or ovarian cancer
    Meeting Abstract

    Hyman, D.; Bonafede, M.; O'Cearbhaill, R.; Grisham, R.; Zamarin, D.; Tew, W.; Aghajanian, C.; Cadoo, K.; Friedman, C.; Savage, R. E.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Cell-free DNA sequencing in ERBB2-mutant breast cancer patients treated with neratinib and fulvestrant: Exploratory analysis from the phase 2 SUMMIT 'basket' trial
    Meeting Abstract

    Schram, A. M.; Selcuklu, S. D.; Nagy, R. J.; Smyth, L. M.; Eli, L. D.; Cutler, R. E.; Lalani, A. S.; Hyman, D. M.; Lanman, R. B.
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Phase II study of gemcitabine, trastuzumab, and pertuzumab for HER2-Positive metastatic breast cancer after prior pertuzumab-based therapy
    Meeting Abstract

    Iyengar, N. M.; Smyth, L.; Lake, D.; Gucalp, A.; Singh, J. C.; Traina, T. A.; DeFusco, P.; Dickler, M. N.; Fornier, M. N.; Goldfarb, S.; more...
    Cancer Research (2017)

    Fulltext@MSK | Save
  • A phase I safety study of topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopecia (CIA)
    Meeting Abstract

    Goldfarb, S. B.; Konner, J.; Stevens, J.; Brouwer, S.; Narain, N. R.; Ye, R.; Ravipaty, S.; Sarangarajan, R.; Akmaev, V. R.; Jimenez, J. J.; more...
    Cancer Research (2017)

    Fulltext@MSK | Save
  • Phase 2 study of dose-dense doxorubicin and cyclophosphamide followed by eribulin mesylate with or without prophylactic growth factor for adjuvant treatment of early-stage breast cancer
    Meeting Abstract

    Cadoo, K.; Kaufman, P. A.; Hudis, C.; Chang, C.; Berrak, E.; Song, J.; Seidman, A. D.; Traina, T. A.
    Cancer Research (2016)

    Fulltext@MSK | Save
  • A phase I trial of ganetespib (heat shock protein 90 inhibitor) in combination with paclitaxel and trastuzumab in patients with human epidermal growth factor receptor-2 positive (HER2+) metastatic breast cancer (MBC)
    Meeting Abstract

    Jhaveri, K.; Teplinsky, E.; Chandarlapaty, S.; Solit, D.; Cadoo, K.; Speyer, J.; D'Andrea, G.; Adams, S.; Patil, S.; Haque, S.; more...
    Cancer Research (2016)

    Fulltext@MSK | Save
  • Phase I of oral BKM120 or BYL719 and olaparib for high-grade serous ovarian cancer or triple-negative breast cancer: Final results of the BKM120 plus olaparib cohort
    Meeting Abstract

    Matulonis, U. A.; Wulf, G.; Barry, W.; Birrer, M.; Westin, S.; Spagnoletti, T.; Bell-McGuinn, K.; Obermayer, E.; Whalen, C.; Aghajanian, C.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Ado-trastuzumab emtansine for HER2 amplified or HER2 overexpressed cancers: A phase II "basket" trial
    Meeting Abstract

    Li, B. T.; Zauderer, M.; Chaft, J.; Drilon, A.; Eng, J.; Sima, C.; Makker, V.; Iyer, G.; Janjigian, Y.; Hyman, D.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • A phase I clinical trial of ganetespib (heat shock protein 90 inhibitor) in combination with paclitaxel and trastuzumab in human epidermal growth factor receptor-2 positive (HER2+) metastatic breast cancer
    Meeting Abstract

    Jhaveri, K.; Cadoo, K.; Chandarlapaty, S.; Teplinsky, E.; Speyer, J.; D'Andrea, G.; Patil, S.; Haque, S.; Friedman, K.; Heese, S.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save

    • Cancer Research – authorized name for:

    Name ISSN / ISBN Publisher
    Cancer Research 0008-5472 American Association for Cancer Research
    Cancer Research 15387445 American Association for Cancer Research
    Cancer Research 0008-5472 American Association for Cancer Research
    Cancer Research 00085472 American Association for Cancer Research
    Cancer Research 0008-5472 American Association for Cancer Research
    Cancer Research 00085472 American Association Tor Cancer Research
    Cancer Research 00085472 American Association for Cancer Research
    Cancer Research 0008-5472 American Association for Cancer Research
    Cancer Research 0008-5472 Unknown
    Cancer research 15387445 The Authors the American Association for Cancer Research
    Cancer Research 00085472 American Association for Cancer Research
    Cancer Research 15387445 American Association for Cancer Research
    Cancer research 15387445 American Association for Cancer Research
    Cancer Research 00085472 Unknown
    Cancer Research 00085472 American Association for Cancer Research
    Cancer Research 0008-5472 American Association for Cancer Research
    Cancer research 15387445 Unknown
    Cancer Research 0008-5472 American Association for Cancer Research
    Cancer Research 0008-5472 American Association for Cancer Research
    Cancer Research 0008-5472 American Association for Cancer Research
    Cancer Research 00085472 American Association for Cancer
    Cancer Research 00085472 The Authors
    Cancer Research 00085472 The Authors the American Association for Cancer Research